Wisconsin Eyes the Horizon: Federal Marijuana Reclassification and Local Impacts

Wisconsin Stands at a Crossroads as Federal Marijuana Regulations Loosen

Listen: Wisconsin Legal Weed

Summary

• Federal authorities in the United States are considering loosening regulations on marijuana, which has sparked interest among proponents in Wisconsin.
• However, local advocates do not expect immediate changes in the stance of Republican lawmakers in the state.

Federal authorities are considering relaxing the regulations surrounding marijuana, sparking interest among its proponents in Wisconsin. Despite this potential shift at the federal level, local advocates do not anticipate immediate changes in the stance of Republican lawmakers in the state, who have historically been divided on the issue of medical marijuana and against the legalization of its recreational use.

This week, the U.S. Department of Justice proposed reclassifying marijuana, initiating a detailed process that could eventually moderate the constraints on its production and research. Presently classified as a Schedule I drug by the Drug Enforcement Administration—equivalent to heroin and LSD—the DOJ suggests repositioning it to Schedule III, alongside substances like ketamine, anabolic steroids, and Tylenol with codeine. Such a move would represent a significant shift in federal policy, yet full legalization advocates in Wisconsin remain skeptical of a change in perspective among state Republicans who have consistently opposed legalization efforts and struggled to reach an agreement on medical usage within their party.

Jay Selthofner, Director of the Wisconsin Cannabis Activist Network, noted that federal reclassification would not directly influence state decisions on legalization but could facilitate broader cannabis research under a less restrictive classification.

To date, 38 states have authorized medical cannabis, and 24 have approved its recreational use, including Illinois, Michigan, and Minnesota since 2018. Public opinion in Wisconsin has also evolved, with recent polls indicating increasing support for legalization. A Marquette University Law School survey highlighted a rise in approval for legalizing marijuana from 50% in 2013 to 63% in early 2023, with a strong majority also supporting its medicinal use.

State Senator Melissa Agard, a vocal advocate for legalization, expressed optimism that the federal government’s reevaluation of cannabis policy might pave the way for bipartisan consensus in Wisconsin. She highlighted the federal classification of cannabis as a significant barrier cited by her colleagues and anticipates that upcoming legislative changes could align more closely with public sentiment toward cannabis legalization.

Earlier this year, Wisconsin Republicans proposed a highly restrictive medical marijuana bill, emphasizing that it would not extend to recreational use. The proposed legislation, which encountered opposition within the state Senate, outlined strict conditions for medical usage and limited the forms of cannabis to non-smokable options.

Despite these developments, key political figures in Wisconsin, including Republican Assembly Speaker Robin Vos, have maintained a cautious approach, with Vos describing the proposed program as potentially the most restrictive in the country. The lack of consensus highlights the ongoing debate within the state over marijuana policy reform and its implications for residents’ rights and state revenue, with a fiscal estimate suggesting significant tax income from legalized marijuana sales.